Prolactin Levels in Breast Cancer Patients
Author Information
Author(s): P.R. Maddox, D.L. Jones, R.E. Mansel
Primary Institution: University Department of Surgery, University of Wales College of Medicine
Hypothesis
Are basal prolactin and total lactogenic hormone levels elevated in breast cancer patients compared to controls?
Conclusion
Breast cancer patients have significantly elevated levels of bioactive prolactin compared to age-matched controls.
Supporting Evidence
- Bioactive prolactin levels were significantly elevated in breast cancer patients compared to controls.
- 61% of breast cancer patients had elevated BA IRMA prolactin ratios above the upper limit of normal.
- The study used both a new microbioassay and conventional immunoassay to measure hormone levels.
Takeaway
This study found that women with breast cancer have higher levels of a hormone called prolactin compared to women without breast cancer.
Methodology
The study measured prolactin and total lactogenic hormone levels in 33 breast cancer patients and 40 age-matched controls using a microbioassay and immunoassay.
Limitations
The study excluded patients with endocrinological disorders and those on certain medications, which may limit generalizability.
Participant Demographics
33 breast cancer patients and 40 age-matched normal female volunteers, with a majority being postmenopausal.
Statistical Information
P-Value
p<0.0001
Statistical Significance
p<0.0001
Want to read the original?
Access the complete publication on the publisher's website